Organization (Industry)
BAUSCH HEALTH COMPANIES INC.
ClinicalTrials.gov lists BAUSCH HEALTH COMPANIES INC. as lead sponsor of 445 trials, counting the companies grouped under it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Rows recorded per section
1 more section with rows · 15 sections measured, none recorded
This page covers BAUSCH HEALTH COMPANIES INC. and 6 companies grouped under it: 445 lead-sponsored trials (0 its own, 445 in the grouped companies) and 5 legal-entity registrations (2 its own, 3 in the grouped companies).
Companies grouped under this page (6)
Shown in this order: most lead trials first.
| Company | Lead trials | Legal entities |
|---|---|---|
| Bausch & Lomb Incorporated | 225 | 3 |
| Bausch Health Americas, Inc. | 213 | 0 |
| Solta Medical | 4 | 0 |
| PreCision Dermatology, Inc. | 2 | 0 |
| Laboratorios Grossman, S.A. | 1 | 0 |
Showing 5 of 6 member companies.
US granted patents (1)
Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.
| US patents granted | Granted in the last 5 years | Most recent grant |
|---|---|---|
| 29 | 1 | 2023-02-28 |
FDA untitled letters (1)
| Issue date | Letter |
|---|---|
| 2025-09-09 | 188749 |
FDA inspection record (1)
| Latest classification | Inspections |
|---|---|
| NAI | 16 |
FDA recalls (8)
Shown in this order: most recent first.
| Product | Classification | Initiated |
|---|---|---|
| Omeprazole and Sodium Bicarbonate For Oral Suspension 40mg/1,680mg, This packet contains 40mg of omeprazole and 1,680mg of sodium bicarbonate, Directions for Use: Empty packet contents into a small cup containing 1 to 2 tablespoons of WATER. DO NOT USE OTHER LIQUIDS OR FOODS. Stir well and drink immediately. Rx Only, Distributed by: Oceanside Pharmaceuticals, a division of Bausch Health US, LLC, Bridgewater, NJ 08807, NDC 68682-991-30. | Class II | 2024-02-02 |
| Mephyton (Phytonadione) 5 mg tablets, 100-count tablets, Rx Only, Manufactured for: Valeant Pharmaceuticals North America, LLC, Bridgewater, NJ, 08807, USA, NDC 0187-1704-05. | Class III | 2021-06-08 |
| Phytonadione Tablets, 5 mg, 30-count ablets, Rx only, Manufactured for: Oceanside Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807 USA, NDC 68682-170-30 | Class III | 2021-06-08 |
| Mephyton (phytonadione) Tablets 5mg, 100-count bottle, Rx Only, Manufactured for: Valeant Pharmaceuticals North America, LLC Bridgewater, NJ 08807 USA NDC 0187-1704-05 | Class III | 2021-01-07 |
| Phytonadione Tablets 5mg, 30-count bottle, Rx Only, Manufactured For: Oceanside Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC Bridgewater, NJ 08807 USA NDC 68682-170-30 | Class III | 2021-01-07 |
Showing 5 of 8 recalls.
FDA import refusals (1)
| Refused import lines | Latest refusal |
|---|---|
| 53 | 2026-04-16 |
Manufacturing and distribution sites (2)
Shown in this order: severity rank then name.
| Facility | Location | Regulators | Member organization |
|---|---|---|---|
| Bausch Health Companies Inc. | Laval, CA | FDA, Health Canada | |
| Bausch Health Companies Inc. | Steinbach, CA | FDA, Health Canada |
Organization relationships (1)
| Related organization | Relationship | Evidence |
|---|---|---|
| Bausch & Lomb Corp | Ultimate parent of | 1 |
Latest dated events (206)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-06-02 | FDA import refusal | FDA enforcement (warning and untitled letters, recalls, inspections, import refusals, debarment) |
| 2026-04-16 | FDA import refusal | FDA enforcement (warning and untitled letters, recalls, inspections, import refusals, debarment) |
| 2025-12-22 | FDA import refusal | FDA enforcement (warning and untitled letters, recalls, inspections, import refusals, debarment) |
| 2025-12-01 | FDA import refusal | FDA enforcement (warning and untitled letters, recalls, inspections, import refusals, debarment) |
| 2025-11-21 | FDA import refusal | FDA enforcement (warning and untitled letters, recalls, inspections, import refusals, debarment) |
Showing 5 of 206 events.
Not on this page
Checked, with nothing recorded for this organization: related companies not grouped here, disease areas, trials by start year as sponsor or collaborator, active development programs, approved assets, sponsor delivery record, journals published in, sec-reported annual financials, financing and grant events, fda warning letters, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, biomarker capability evidence, and biomarkers this organization publishes on.